Trials / Conditions / Unresectable Liposarcoma
Unresectable Liposarcoma
6 registered clinical trials studyying Unresectable Liposarcoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma NCT06843967 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Recruiting | BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma NCT06414434 | Michael Wagner, MD | Phase 1 |
| Active Not Recruiting | Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advan NCT05836571 | National Cancer Institute LAO | Phase 2 |
| Terminated | Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot NCT03074318 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot B NCT03009201 | OHSU Knight Cancer Institute | Phase 1 |
| Completed | Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Su NCT02500797 | National Cancer Institute (NCI) | Phase 2 |